Alzheimer's disease (AD) is on track to become one of the defining public health challenges of our time. Every three seconds, somewhere in the world, someone is diagnosed with dementia, and it's ...

The lead investigators of different Alzheimer's disease (AD) prevention trials have banded together to share information, resources, and expertise with the singular goal of finding ways to postpone, ...

Despite billions of dollars of research, the healthcare industry is still struggling to control the immense challenge posed by Alzheimer’s Disease (AD). However, now research advances are improving ...

AC Immune SA announced its participation in the upcoming International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025) in Vienna, Austria, from April 1-5, 2025, where it will showcase ...